AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimnof-M2 Tablet PR

Prescription Icon
Prescription Required

Marketer

Cenofi Healthcare Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimnof-M2 Tablet PR

Diabex Duo tablets are a dual-action antidiabetic medication prescribed for adult patients with type 2 diabetes. This combination therapy helps regulate blood glucose. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most prevalent side effect is hypoglycemia (low blood sugar). Familiarize yourself with its symptoms—sweating, dizziness, headache, trembling—and appropriate countermeasures. Regular meals and readily available fast-acting glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is a possibility for some individuals. Diabex Duo is contraindicated for patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Its suitability for pregnant or breastfeeding women must be assessed by a healthcare professional. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Glimnof-M2 Tablet PR

No text provided. Please provide the text you wish me to rephrase.

Uses of Glimnof-M2 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimnof-M2 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Administer Glimnof-M2 Tablet PR with a meal.

Common Side effects of Glimnof-M2 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimnof-M2 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for dosage guidance. Administer Glimnof-M2 Tablet PR with a meal.

How Glimnof-M2 Tablet PR works:

Glimnof-M2 Tablet PR combines glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol consumption while taking Glimnof-M2 Tablet PR.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimnof-M2 Tablet PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glimnof-M2 Tablet PR. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Glimnof-M2 Tablet PR requires careful administration in individuals with impaired kidney function. Dosage modification of Glimnof-M2 Tablet PR might be necessary. Physician consultation is recommended. Glimnof-M2 Tablet PR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimnof-M2 Tablet PR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, initiation should be at a low dose; Glimnof-M2 Tablet PR is contraindicated in patients with severe liver disease.

What if you forget to take Glimnof-M2 Tablet PR :

Should you forget a dose of Glimnof-M2 Tablet PR, ingest it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimnof-M2 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimnof-M2 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimnof-M2 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimnof-M2 Tablet PR and seek immediate medical attention.
Glimnof-M2 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Glimnof-M2 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimnof-M2 Tablet PR use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimnof-M2 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimnof-M2 Tablet PR and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimnof-M2 Tablet PR
53
MRP 64
17% off